ZIM
DXCM icon

Zacks Investment Management’s DexCom DXCM Stock Holding History

Zacks Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,820
Closed -$3.33M – 603
2021
Q4 		$3.33M Buy
24,820
+4,932
+25% +$709K 0.05% 236
2021
Q3 		$2.72M Buy
+19,888
New +$2.51M 0.04% 255
2021
Q1 		– Sell
-20,416
Closed -$1.89M – 525
2020
Q4 		$1.89M Buy
20,416
+1,416
+7% +$126K 0.03% 271
2020
Q3 		$1.96M Buy
19,000
+3,532
+23% +$369K 0.04% 231
2020
Q2 		$1.57M Sell
15,468
-3,020
-16% -$270K 0.03% 236
2020
Q1 		$1.24M Buy
+18,488
New +$1.15M 0.03% 265

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zacks Investment Management's DXCM Position: Q1 2022 in Review

Zacks Investment Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 24,820 shares — an estimated $3.33M sold.

Zacks Investment Management first reported a position in DXCM in Q1 2020 and held it in 6 quarters. The position peaked at $3.33M in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Zacks Investment Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Zacks Investment Management sold 24,820 DexCom shares in Q1 2022, an estimated $3.33M.
  • Zacks Investment Management first reported a position in DexCom in Q1 2020 and held it in 6 quarters.
  • Zacks Investment Management's DexCom position peaked at $3.33M in Q4 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Zacks Investment Management's 13F filing for Q1 2022, filed 13 May 2022.